Healthcare provider profile · identity verified

Ellen Hand, MD

Internal Medicine · SUN CITY, AZ · NPI 1477533479

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	569	170
Rosuvastatin Calcium	Rosuvastatin Calcium	487	153
Atorvastatin Calcium	Atorvastatin Calcium	444	140
Levothyroxine Sodium	Levothyroxine Sodium	383	116
Lisinopril	Lisinopril	369	112
Losartan Potassium	Losartan Potassium	274	87
Hydrochlorothiazide	Hydrochlorothiazide	257	70
Metformin Hcl	Metformin Hcl	252	82
Gabapentin	Gabapentin	245	90
Alendronate Sodium	Alendronate Sodium	243	85
Omeprazole	Omeprazole	235	70
Metoprolol Succinate	Metoprolol Succinate	191	60
Pantoprazole Sodium	Pantoprazole Sodium	176	59
Escitalopram Oxalate	Escitalopram Oxalate	148	48
Simvastatin	Simvastatin	147	45
Tramadol Hcl	Tramadol Hcl	109	28
Atenolol	Atenolol	108	31
Metoprolol Tartrate	Metoprolol Tartrate	108	30
Trazodone Hcl	Trazodone Hcl	106	40
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	98	18
Synthroid	Levothyroxine Sodium	98	31
Eliquis	Apixaban	89	22
Mounjaro	Tirzepatide	81	18
Duloxetine Hcl	Duloxetine Hcl	80	29
Farxiga	Dapagliflozin Propanediol	80	24
Fluticasone Propionate	Fluticasone Propionate	78	44
Famotidine	Famotidine	74	29
Glipizide	Glipizide	70	23
Furosemide	Furosemide	69	25
Metformin Hcl Er	Metformin Hcl	69	28
Albuterol Sulfate Hfa	Albuterol Sulfate	65	41
Clopidogrel	Clopidogrel Bisulfate	63	21
Venlafaxine Hcl Er	Venlafaxine Hcl	62	16
Carvedilol	Carvedilol	60	21
Solifenacin Succinate	Solifenacin Succinate	59	23
Lorazepam	Lorazepam	58	17
Sertraline Hcl	Sertraline Hcl	57	21
Hydralazine Hcl	Hydralazine Hcl	56	20
Citalopram Hbr	Citalopram Hydrobromide	55	19
Enalapril Maleate	Enalapril Maleate	50	13
Warfarin Sodium	Warfarin Sodium	46	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	13
Baclofen	Baclofen	44	24
Tamsulosin Hcl	Tamsulosin Hcl	41	13
Donepezil Hcl	Donepezil Hcl	39	13
Allopurinol	Allopurinol	37	13
Potassium Chloride	Potassium Chloride	37	15
Pravastatin Sodium	Pravastatin Sodium	37	15
Buspirone Hcl	Buspirone Hcl	36	13
Ezetimibe	Ezetimibe	36	15
Glipizide Er	Glipizide	36	14
Pregabalin	Pregabalin	36	12
Shingrix	Varicella-Zoster Ge/As01b/Pf	35	23
Acyclovir	Acyclovir	34	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	28
Alprazolam	Alprazolam	29	11
Azelastine Hcl	Azelastine Hcl	29	17
Fluoxetine Hcl	Fluoxetine Hcl	29	12
Prednisone	Prednisone	29	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	11
Clonazepam	Clonazepam	28	suppressed
Estradiol	Estradiol	28	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	27	27
Montelukast Sodium	Montelukast Sodium	27	suppressed
Ozempic	Semaglutide	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Arnuity Ellipta	Fluticasone Furoate	25	suppressed
Bupropion Xl	Bupropion Hcl	25	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	14
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Finasteride	Finasteride	23	suppressed
Amoxicillin	Amoxicillin	22	13
Memantine Hcl	Memantine Hcl	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Pentips Pen Needle	Pen Needle, Diabetic	21	suppressed
Valsartan	Valsartan	21	suppressed
Nabumetone	Nabumetone	20	17
Felodipine Er	Felodipine	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Humulin N	Insulin Nph Human Isophane	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	15
Hydrocortisone	Hydrocortisone	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Cephalexin	Cephalexin	17	12
Jardiance	Empagliflozin	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Nystatin	Nystatin	16	13
Trueplus Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	12
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Humalog	Insulin Lispro	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Klor-Con M10	Potassium Chloride	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error